HHS committee to recommend lab test oversight

Share this article:
As DTC promoters push all kinds of genetic tests, a high-level HHS advisory committee is preparing to recommend that FDA should have some level of oversight for all lab tests, including the more than 1,100 genetic tests now offered by hundreds of labs across the nation. 
Share this article:
You must be a registered member of MMM to post a comment.

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters